Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase.
D000818:Animals; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005354:Fibrosarcoma / Q000517:prevention & control / Q000628:therapy*; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D009439:Neuraminidase / Q000627:therapeutic use*; D012513:Sarcoma, Experimental / Q000517:prevention & control / Q000628:therapy
D001500:BCG Vaccine; D009439:Neuraminidase